Patients with acute myocardial infarction thrombolytic therapy.docVIP

 PAGE \* MERGEFORMAT 9 Patients with acute myocardial infarction thrombolytic therapy [Abstract] Objective To summarize the intravenous thrombolytic therapy for acute myocardial infarction experience. Method to our hospital in January 2007 ~ December 2009 of 100 patients hospitalized with acute myocardial infarction were randomly divided into urokinase thrombolytic therapy group 50 cases and the conventional therapy group of 50 patients, the clinical efficacy and complications. Results coronary reperfusion thrombolytic therapy group, cardiac function improved, severe arrhythmia and death rates were 84.0%, 8.0%, 6.0%, 2.0% conventional coronary reperfusion therapy group, cardiac function improved, severe arrhythmia and death rates were 60.0%, 20%, 12.0%, 8.0%. the two groups, the difference was statistically significant, P lt;0.05. the two groups bleeding complications, the difference was not significant, Pgt; 0.05. Conclusion urokinase thrombolytic therapy for acute myocardial infarction is simple, safe, effective and worth promoting. [Keywords:] intravenous thrombolysis with urokinase in acute myocardial infarction coronary reperfusion hemorrhage Intravenous thrombolytic therapy in acute myocardial infarction can (AMI patients with myocardial infarction associated with coronary occlusion and reperfusion, to save the ischemic myocardium, reduce infarct size, improve cardiac function and patient survival, is one of the primary means of treatment of AMI . our hospital in January 2007 ~ December 2009 intravenous thrombolytic therapy with urokinase in 50 patients with acute myocardial infarction, and achieved good effect, are reported as follows: 1 Materials and Methods 1.1 Clinical data Choose our hospital in January 2007 -2009 hospitalized in December of 100 patients with acute myocardial infarction, all patients are in line with lt;lt;acute myocardial infarction diagnosis and treatment guidelinesgt;gt; in the standard thrombolytic indication